Practical application of new technologies for melanoma diagnosis: Part II. Molecular approaches.
暂无分享,去创建一个
Matthew Hand | M. Hand | D. Grossman | Douglas Grossman | J. March | A. Truong | Jordon March | Amanda Truong | Jordon K. March
[1] K. Duffy,et al. The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspects. , 2012, Journal of the American Academy of Dermatology.
[2] M. Mihm,et al. Deep penetrating nevus-like borderline tumors: A unique subset of ambiguous melanocytic tumors with malignant potential and normal cytogenetics , 2014, European Journal of Dermatology.
[3] B. Bastian,et al. Assessment of Copy Number Status of Chromosomes 6 and 11 by FISH Provides Independent Prognostic Information in Primary Melanoma , 2011, The American journal of surgical pathology.
[4] D. Schadendorf,et al. Somatic alterations in the melanoma genome: A high‐resolution array‐based comparative genomic hybridization study , 2010, Genes, chromosomes & cancer.
[5] Xinmin Li,et al. De novo congenital melanoma: analysis of 2 cases with array comparative genomic hybridization. , 2014, The American Journal of dermatopathology.
[6] J. Guitart,et al. A Highly Specific and Discriminatory FISH Assay for Distinguishing Between Benign and Malignant Melanocytic Neoplasms , 2012, The American journal of surgical pathology.
[7] Yu Fang,et al. Fluorescence in Situ Hybridization for Distinguishing Nevoid Melanomas From Mitotically Active Nevi , 2009, The American journal of surgical pathology.
[8] S. Sait,et al. Chromosome changes in metastatic human melanoma. , 1988, Cancer genetics and cytogenetics.
[9] John Quackenbush,et al. Melanoma mimic: a case of multiple pagetoid Spitz nevi. , 2012, Archives of dermatology.
[10] H. S. Robin,et al. Development of a novel noninvasive adhesive patch test for the evaluation of pigmented lesions of the skin. , 2014, Journal of the American Academy of Dermatology.
[11] H. Bangash,et al. What's new in prognostication of melanoma in the dermatopathology laboratory? , 2013, Clinics in dermatology.
[12] R. Corona,et al. Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] E. Farmer,et al. Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists. , 1996, Human pathology.
[14] S. Swetter,et al. Fluorescence In Situ Hybridization Analysis of Atypical Melanocytic Proliferations and Melanoma in Young Patients , 2014, Pediatric dermatology.
[15] S. Diaz‐Cano. Paratumoral gene expression profiles: promising markers of malignancy in melanocytic lesions , 2011, The British journal of dermatology.
[16] S. Lodha,et al. Discordance in the histopathologic diagnosis of difficult melanocytic neoplasms in the clinical setting , 2008, Journal of cutaneous pathology.
[17] U. Francke,et al. Cytogenetic analysis of melanocytes from premalignant nevi and melanomas. , 1988, Journal of the National Cancer Institute.
[18] E. Nagore,et al. Fluorescence in situ hybridization for the differential diagnosis between Spitz naevus and spitzoid melanoma , 2012, Histopathology.
[19] A. D. Thompson,et al. Current applications of molecular genetic technologies to the diagnosis and treatment of cutaneous melanocytic neoplasms. , 2013, Clinics in laboratory medicine.
[20] J. Guitart,et al. Atypical Spitz Tumors With 6q23 Deletions: A Clinical, Histological, and Molecular Study , 2013, The American Journal of dermatopathology.
[21] D. Bostwick,et al. Differentiation of melanoma and benign nevi by fluorescence in-situ hybridization , 2011, Melanoma research.
[22] I. Yeh,et al. Melanoma ex blue nevus: two cases resembling large plaque‐type blue nevus with subcutaneous cellular nodules , 2012, Journal of cutaneous pathology.
[23] N. Kolaitis,et al. Fluorescence In Situ Hybridization as an Ancillary Tool in the Diagnosis of Ambiguous Melanocytic Neoplasms: A Review of 804 Cases , 2014, The American journal of surgical pathology.
[24] L. Cerroni,et al. Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases , 2011, Modern Pathology.
[25] Sean Davis,et al. Chromothripsis and focal copy number alterations determine poor outcome in malignant melanoma. , 2013, Cancer research.
[26] D. Pinkel,et al. Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma. , 1999, The Journal of investigative dermatology.
[27] R. González-Cámpora,et al. Application of fluorescence in situ hybridization as a diagnostic tool in melanocytic lesions, using paraffin wax‐embedded tissues and imprint‐cytology specimens , 2012, Clinical and experimental dermatology.
[28] J. Guitart,et al. Distinguishing Epithelioid Blue Nevus From Blue Nevus-like Cutaneous Melanoma Metastasis Using Fluorescence In Situ Hybridization , 2009, The American journal of surgical pathology.
[29] R. Iyer,et al. Copy Number Variations and Clinical Outcome in Atypical Spitz Tumors , 2011, American Journal of Surgical Pathology.
[30] S. Jhanwar,et al. Fluorescence In Situ Hybridization (FISH) Analysis of Melanocytic Nevi and Melanomas , 2012, International journal of surgical pathology.
[31] A. Quattrone,et al. Increased frequency of minimal homozygous deletions is associated with poor prognosis in primary malignant melanoma patients , 2014, Genes, chromosomes & cancer.
[32] M. van de Rijn,et al. High-Resolution Array-Based Comparative Genomic Hybridization for Distinguishing Paraffin-Embedded Spitz Nevi and Melanomas , 2004, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[33] J. Guitart,et al. Fluorescence in situ hybridization as a tool for microstaging in malignant melanoma , 2009, Modern Pathology.
[34] C. Garbe,et al. Recurrent nodules in a periauricular plaque‐type blue nevus with fatal outcome , 2012, Journal of cutaneous pathology.
[35] A. Rademaker,et al. Copy number gains in 11q13 and 8q24 [corrected] are highly linked to prognosis in cutaneous malignant melanoma. , 2011, The Journal of molecular diagnostics : JMD.
[36] D. Pinkel,et al. Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. , 1998, Cancer research.
[37] W. Kuo,et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays , 1998, Nature Genetics.
[38] R. Gasparini,et al. FISH as an effective diagnostic tool for the management of challenging melanocytic lesions , 2011, Diagnostic pathology.
[39] S. Fox,et al. Loss of CDKN2A expression is a frequent event in primary invasive melanoma and correlates with sensitivity to the CDK4/6 inhibitor PD0332991 in melanoma cell lines , 2014, Pigment cell & melanoma research.
[40] T. Mentzel,et al. A Proposal for Improving Multicolor FISH Sensitivity in the Diagnosis of Malignant Melanoma Using New Combined Criteria , 2012, The American Journal of dermatopathology.
[41] D. Pinkel,et al. Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors , 2022 .
[42] M. Tetzlaff,et al. Ambiguous Melanocytic Tumors in a Tertiary Referral Center: The Contribution of Fluorescence In Situ Hybridization (FISH) to Conventional Histopathologic and Immunophenotypic Analyses , 2013, The American journal of surgical pathology.
[43] C. Lewis,et al. A multiobserver, population-based analysis of histologic dysplasia in melanocytic nevi. , 1994, Journal of the American Academy of Dermatology.
[44] P. Gerami,et al. Update on fluorescence in situ hybridization in melanoma: state of the art. , 2011, Archives of pathology & laboratory medicine.
[45] A. Theos,et al. Mitotically active proliferative nodule arising in a giant congenital melanocytic nevus: a diagnostic pitfall. , 2013, The American Journal of dermatopathology.
[46] G. Mann,et al. Diagnosis of cutaneous melanocytic tumours by four‐colour fluorescence in situ hybridisation , 2009, Pathology.
[47] P. Nowell,et al. Cytogenetics of human malignant melanoma and premalignant lesions. , 1984, Cancer genetics and cytogenetics.
[48] J. Fridlyand,et al. Distinct sets of genetic alterations in melanoma. , 2005, The New England journal of medicine.
[49] R. Ádány,et al. Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization , 2012, Melanoma research.
[50] V. Sondak,et al. Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[51] A. Marghoob,et al. Integrating clinical/dermatoscopic findings and fluorescence in situ hybridization in diagnosing melanocytic neoplasms with less than definitive histopathologic features. , 2012, Journal of the American Academy of Dermatology.
[52] J. Tschen,et al. Intratumoral heterogeneity of chromosome 9 loss and CDKN2A (p16) protein expression in a morphologically challenging spitzoid melanoma. , 2013, The American Journal of dermatopathology.
[53] D. Elder,et al. Identification of high-risk patients among those diagnosed with thin cutaneous melanomas. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[54] E. Mardis,et al. A 50-Gene Intrinsic Subtype Classifier for Prognosis and Prediction of Benefit from Adjuvant Tamoxifen , 2012, Clinical Cancer Research.
[55] D. Polsky,et al. Noninvasive genomic detection of melanoma , 2011, The British journal of dermatology.
[56] S. Lyle,et al. Correlation between histologic assessment and fluorescence in situ hybridization using MelanoSITE in evaluation of histologically ambiguous melanocytic lesions. , 2012, Archives of pathology & laboratory medicine.
[57] J. Guitart,et al. Sensitivity of fluorescence in situ hybridization for melanoma diagnosis using RREB1, MYB, Cep6, and 11q13 probes in melanoma subtypes. , 2010, Archives of dermatology.
[58] J. Grichnik. Stratum corneum RNA levels are diagnostic for melanoma , 2011, The British journal of dermatology.
[59] A. Enk,et al. Classifying ambiguous melanocytic lesions with FISH and correlation with clinical long-term follow up , 2010, Modern Pathology.
[60] L. Morrison,et al. Fluorescence In Situ Hybridization (FISH) as an Ancillary Diagnostic Tool in the Diagnosis of Melanoma , 2009, The American journal of surgical pathology.
[61] M. Mihm,et al. Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. , 1999, Human pathology.
[62] A. Dar,et al. Prognostic Impact of PHIP Copy Number in Melanoma: Linkage to Ulceration , 2013, The Journal of investigative dermatology.
[63] Daniel Pinkel,et al. Classifying melanocytic tumors based on DNA copy number changes. , 2003, The American journal of pathology.
[64] T. Stricker,et al. Nevus Versus Melanoma: to FISH, or Not to FISH , 2011, Advances in anatomic pathology.
[65] J. Guitart,et al. Enhanced Detection of Spitzoid Melanomas Using Fluorescence In Situ Hybridization With 9p21 as an Adjunctive Probe , 2012, The American journal of surgical pathology.
[66] D. Elder,et al. Risk Assessment for Atypical Spitzoid Melanocytic Neoplasms Using FISH to Identify Chromosomal Copy Number Aberrations , 2013, The American journal of surgical pathology.
[67] B. Bastian,et al. Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool , 2006, Dermatologic therapy.
[68] C. Garbe,et al. Proliferative activity, chromosomal aberrations, and tumor-specific mutations in the differential diagnosis between blue nevi and melanoma. , 2013, The American journal of pathology.
[69] T. McCalmont. Fillet of FISH , 2011, Journal of cutaneous pathology.
[70] K. Duffy,et al. The dysplastic nevus: from historical perspective to management in the modern era: part II. Molecular aspects and clinical management. , 2012, Journal of the American Academy of Dermatology.
[71] N. Kolaitis,et al. Use of Fluorescence In situ Hybridization (FISH) to Distinguish Intranodal Nevus From Metastatic Melanoma , 2010, The American journal of surgical pathology.
[72] D. Pinkel,et al. Genetic changes in neoplasms arising in congenital melanocytic nevi: differences between nodular proliferations and melanomas. , 2002, The American journal of pathology.
[73] Robert W Cook,et al. Development of a Prognostic Genetic Signature to Predict the Metastatic Risk Associated with Cutaneous Melanoma , 2015, Clinical Cancer Research.
[74] L. Mazzucchelli,et al. Presence of cytogenetic abnormalities in Spitz naevi: a diagnostic challenge for fluorescence in‐situ hybridization analysis , 2012, Histopathology.
[75] C. Garbe,et al. Molecular genetic classification of difficult melanocytic tumors , 2013, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[76] D. Elder,et al. Outcomes of Atypical Spitz Tumors With Chromosomal Copy Number Aberrations and Conventional Melanomas in Children , 2013, The American journal of surgical pathology.
[77] K. Nishioka,et al. Genomic alterations in primary cutaneous melanomas detected by metaphase comparative genomic hybridization with laser capture or manual microdissection: 6p gains may predict poor outcome. , 2005, Cancer genetics and cytogenetics.
[78] T. Godfrey,et al. Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. , 2000, Cancer research.